ChemoCentryx Cash Flow - Quarterly (NASDAQ:CCXI)

Add to My Stocks
$12.37 $0.54 (4.56%) CCXI stock closing price Sep 20, 2018 (Closing)

For analyzing any company like ChemoCentryx from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For ChemoCentryx profits one has to check the income statement and for ChemoCentryx debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in ChemoCentryx stock analysis. ChemoCentryx had a negative net income cash flow of $-16.29M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. The cash from operating activities for ChemoCentryx is $ 2018 Q2, which saw an increase from previous quarter.

View and download details of ChemoCentryx cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-16.29M-9.41M17.85M-21.79M-15.23M-5.99M-39.96M-32.29M-25.22M-15.24M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities60.67M48.07M-22.29M13.66M21.96M29.53M70.04M73.3M76.45M1.65M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net4.69M2.17M8.89M6.9M5.05M2.44M8.71M6.63M4.51M2.39M
Net Cash from (used by) Operating Activities
49.29M40.94M4.87M-0.91M11.98M26.08M39.14M47.89M55.91M-11.11M
Increase (Decrease) in Prop Plant And Equipment-0.63M-0.03M-0.72M-0.37M-0.3M-0.17M-0.3M-0.08M-0.08M-0.06M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-37.31M-51.04M16.32M4.84M-3.67M-19.03M-48.45M-54.38M-54.21M11.56M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-37.94M-51.07M15.6M4.47M-3.98M-19.21M-48.76M-54.47M-54.3M11.5M
Issuance (Purchase) of Equity Shares7.88M1.12M3.26M2.67M1.76M-8.82M7.62M7.48M-
Issuance (Repayment) of Debt Securities9.98M-4.67M-------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.47M-0.47M-0.42M-0.29M-0.29M-0.29M----
Net Cash from (used by) Financing Activities
17.38M-7.51M2.38M1.47M-8.82M7.62M7.48M-
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
28.73M-9.47M27.99M5.93M9.47M6.93M-0.79M1.04M9.1M-
Cash & Equivalents at Beginning of Year40.02M12.02M12.82M16.07M10.25M8.46M40.15M12.05M21.07M75.59M
Cash & Equivalents at Year End68.75M30.55M40.02M17.96M21.5M18.95M12.02M13.86M21.92M13.42M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The ChemoCentryx stock price history and ChemoCentryx stock comparison chart inevitably reflect its cash flow situation.

  • ChemoCentryx saw a positive change in Net Change in Cash and Cash Equivalents of $28.73M till 2018 Q2. Apart from the ChemoCentryx stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • ChemoCentryx increased its cash from operating activities to $49.29M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-37.94M for CCXI stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $17.38M for ChemoCentryx. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For ChemoCentryx Cash Flow

FCF margin
0.52